期刊文献+

肝细胞永生化:实验研究与应用 被引量:3

Immortalization of liver cells: experimental studies and appli- cation
原文传递
导出
摘要 肝细胞是生物人工肝支持系统的核心原材料,原代肝细胞由于体外生存期短、培养困难而限制了它的应用。目前常用的猪肝细胞有感染内源性逆转录病毒之忧。近年来随着分子生物学的发展肝细胞永生化已成为可能。肝细胞的永生化对于药物毒理、生物人工肝支持系统以及肝脏组织工程的研究都具有非常深远的意义。本文就肝细胞永生化的研究现状及应用前景作一综述。 Hepatocyte is the core raw materials of bioartificial liver support system, primary hepatocyte is lim- ited to application because of short survival and difficult cul- ture in vitro. Porcine hepatocyte which has been used re- cently exist the risks of endogenous retrovirus transmission. With the development of molecular biology, it has been pos- sible that hepatocyte is immortalized recently. Immortalized hepatocytes have greatly significant to drug toxicology, bio- artificial liver support system and tissue engineering of liver. Therefore, we will review the prospects for research and application of immortalized hepatocytes.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2010年第2期156-160,共5页 Chinese Journal of Hepatobiliary Surgery
关键词 肝细胞 永生化 研究与应用 Liver cells Immortalization Studies and application
  • 相关文献

参考文献34

  • 1丁义涛,江春平.急性肝功能衰竭现代治疗模式[J].中华肝胆外科杂志,2006,12(10):649-653. 被引量:6
  • 2丁义涛,徐庆祥.人工肝联合肝移植治疗急性肝功能衰竭[J].中华肝胆外科杂志,2006,12(9):589-591. 被引量:6
  • 3张勇,宋良文,尹纪业,王晓民.肝再生增强因子促进肝再生的细胞信号途径研究[J].中华肝胆外科杂志,2007,13(5):328-331. 被引量:6
  • 4Bodnar AG, Ouellette M,Frolkis M, et al. Extension of lifespan by introduction of telomerase into normal human cells. Science, 1998,279 : 349-352.
  • 5Kobayashi N, Fujiwara T, Westerman KA, et al. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science, 2000,287 : 1258-1262.
  • 6Jauregui HO. The technology of biological extracorporeal liver assist devices: from infancy to adolescence. Artif Organs, 1997,21 : 1163-1168.
  • 7Bilir BM, Guinette D, Karrer F, et al. Hepatocyte transplantation in acute liver failure. Liver Transplant,2000,6 : 32-40.
  • 8Tacke S, Bodusch K, Berg A, Denner J. Sensitive and specific detection methods for porcine endogenous retroviruses applicable to experimental and clinical xenotransplantation. Xenotransplantation, 2001,8 : 125.
  • 9Sussman NL, Gislason GT, Conlin CA, et al. The Hepatix extracorporeal liver assist device: initial clinical experience. Artif Organs, 1994,18 : 390-396.
  • 10Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science, 1999, 284: 1168-1170.

二级参考文献57

  • 1丁义涛,徐庆祥,仇毓东,周建新,吴亚夫,唐勤,周文三.人工肝脏在急性肝衰围手术期的合理选择与运用[J].中华肝胆外科杂志,2005,11(2):87-89. 被引量:4
  • 2丁义涛.乙型肝炎相关性肝脏疾病的肝移植治疗[J].肝胆外科杂志,2005,13(2):91-93. 被引量:7
  • 3施晓雷,丁义涛.骨髓干细胞的可塑性及其转化为肝细胞的研究进展[J].世界华人消化杂志,2005,13(24):2813-2817. 被引量:3
  • 4[1]van de Kerkhove MP.Poyck PP,Denrholt T,et al.Liver support therapy:an overview of the AMC-bioartificial liver research.Dig Surg,2005,22(4):254-264.
  • 5[2]Wigg AJ,Padbury RT.Liver support systems:promise and reality.J Gastroenterol Hepatol,2005,20(12):1807-1816.
  • 6[3]Demetriou AA,Brown RS,Busuttil RW,et al.Prospective,randomized.multicenter,controlled trial of a bioartificial liver in treating acute liver failure.Ann Surg,2004,239(5):660-670.
  • 7[4]van de Kerkhove MP,Hoekstra R Chamuleau RA,et al.Clinical application of bioartifieial liver support systems.Ann Surg,2004,240(2):216-230.
  • 8[5]Poyck PP,Hoekstra R,van Wijk AC,et al.Functional and morphological comparison of three primary liver cell types cultured in the AMC bioartificial liver.Liver Transpl,2007,13(4):589-598.
  • 9[6]Schrem H,Kleine M,Borlak J,et al.Physiological incompatibilities of porcine hepatoeytes for clinical liver support.Liver Transpl,2006,12(12):1832-1840.
  • 10[7]Chamuleau RA,Deurholt T,Hoekstra R.Which are the right cells to be used in a bioartificial liver?Metab Brain Dis,2005,20(4):327-335.

共引文献25

同被引文献33

  • 1陈钟.肝细胞移植的临床应用前景[J].南通大学学报(医学版),2009,29(3):157-159. 被引量:1
  • 2Taru Kantola,Suvi Mklin,Anna-Maria Koivusalo,Pirjo Rsnen,Anne Rissanen,Risto Roine,Harri Sintonen,Krister Hckerstedt,Helena Isoniemi.Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure[J].World Journal of Gastroenterology,2010,16(18):2227-2234. 被引量:3
  • 3Sharma R, Greenhough S, Medine CN, et al. Three-dimensional cul- ture of human embryonic stem cell derived hepatic endoderm and its role in bioartificial liver construction. J Biomed Biotechnol, 2010: 236147.DOI:10.1155/2010/236147.
  • 4Poyck PP, Hoekstra R, van Wijk AC, et al. Functional and morpho- logical comparison of three primary liver cell types cultured in the AMC bioartificial liver. Liver Transpl, 2007,13:589-598.
  • 5Xiong A, Austin TW, Lagasse E, et al. Isolation of human fetal liver progenitors and their enhanced proliferation by three-dimensional coculture with endothelial cells. Tissue Eng Part A, 2008,14:995- 1006.
  • 6Barakat O, Abbasi S, Rodriguez G, et al. Use of decellularizedporcine liver for engineering humanized liver organ. J Surg Res, 2012,173:el 1-25.
  • 7Chamuleau RA, Poyck PP, van de Kerkhove MP. Bioartificial liver: its pros and cons. Ther Apher Dial, 2006,10:168-174.
  • 8Friihauf JH, Mertsching H, Gift S, et al. Porcine endogenous retro- virus released by a bioartificial liver infects primary human cells. Liver Int, 2009,29:1553-1561.
  • 9Nibourg GA, Huisman MT, van der Hoeven TV, et al. Stable overex- pression of pregnane X receptor in HepG2 cells increases its poten- tial for bioartificial liver application. Liver Transpl, 201036:1075- 1085.
  • 10Tang N, Wang Y, Wang X, et al. Stable overexpression of arginase I and ornithine transcarbamylase in HepG2 ceils improves its ammo- nia detoxification. J Cell Biochem, 2012,113:518-527.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部